|
|
|
Volumn 24, Issue 5 SUPPL. 16, 1997, Pages
|
|
Pharmacokinetic and pharmacodynamic issues in the treatment of breakthrough pain
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FENTANYL;
FENTANYL CITRATE;
MORPHINE;
MORPHINE 3 GLUCURONIDE;
MORPHINE 6 GLUCURONIDE;
MORPHINE SULFATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OPIATE AGONIST;
OXYCODONE;
SUFENTANIL;
CANCER PAIN;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRANASAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
PAIN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
SUBLINGUAL DRUG ADMINISTRATION;
ADMINISTRATION, CUTANEOUS;
ADMINISTRATION, INTRANASAL;
ADMINISTRATION, ORAL;
ADMINISTRATION, SUBLINGUAL;
BIOLOGICAL AVAILABILITY;
FENTANYL;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
INJECTIONS, INTRAVENOUS;
MORPHINE;
NARCOTICS;
PAIN;
|
|
EID: 0030763250
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (43)
|
|
References (21)
|
